Dermata Therapeutics Inc (DRMA): Reverse split completed watch for new bo...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Re: None

Thursday, 05/16/2024 4:46:42 PM

Thursday, May 16, 2024 4:46:42 PM

Reverse split completed watch for new bottom

Keep Last Read

Replies (1) Next 10 Prev Next

Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 07/15/2024 08:08:05 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 07/15/2024 04:15:18 AM
Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2024 09:06:12 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:01:23 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:00:44 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:00:36 AM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 12/07/2023 09:05:59 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:09:02 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 09:08:14 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/10/2023 08:18:20 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 08:16:30 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/03/2023 08:31:21 PM

InvestorsHub NewsWire

Only $200 per official company press release!